Physician profile
Graham Reimer
NPI 1194958389
$9,031.02
in general payments reported to CMS, 2019-2025
26 companies · $2,084 in 2025
The $2,084 reported for 2025 was more than what 83% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,285 · 2020: $418 · 2021: $442 · 2022: $1,005 · 2023: $1,129 · 2024: $668 · 2025: $2,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,070 · Travel and Lodging: $686 · Consulting Fee: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,069.67 |
| Travel and Lodging | $685.81 |
| Consulting Fee | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,417.33 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Medtronic USA, INC. | $1,990.59 | 2019-2020 | |
| Abbott Laboratories | $1,425.72 | 2019-2025 | Proclaim, Axium |
| Abbvie INC. | $744.03 | 2021-2025 | |
| Nevro Corp. | $682.18 | 2019-2024 | Senza |
| Painteq LLC | $274.74 | 2022-2024 | Painteq |
| Medtronic, INC. | $157.16 | 2023-2025 | Accurian, Inceptiv |
| Nalu Medical, INC. | $154.57 | 2022-2025 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $150.76 | 2024 | Qutenza |
| Collegium Pharmaceutical, INC. | $136.93 | 2019-2025 | Belbuca |
| Globus Medical, INC. | $135.17 | 2025 | Senza |
| Stryker Corporation | $135.08 | 2019-2025 | Mild Device Kit |
| Spr Therapeutics, INC | $113.63 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $106.50 | 2025 | |
| Relievant Medsystems, INC. | $101.67 | 2022-2023 | Intracept |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $78.02 | 2023 | Evoke Scs |
| Flowonix Medical Incorporated | $58.66 | 2019 | |
| Amgen INC. | $24.74 | 2022 | |
| Spinal Simplicity, LLC | $22.96 | 2025 | Ha Minuteman G3-R |
| Teva Pharmaceuticals USA, INC. | $22.61 | 2025 | Ajovy |
| Grt US Holding, INC. | $21.04 | 2021 | |
| Mml US, INC. | $20.45 | 2025 | Reactiv8 |
| Stimwave Technologies Incorporated | $16.17 | 2020 | |
| Biodelivery Sciences International, INC. | $14.81 | 2021 | |
| Depuy Synthes Sales INC. | $14.76 | 2021 | |
| Terumo Bct, INC. | $10.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Graham Reimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.